Medical Treatment of Osteomyelitis due to Carbapenemase-Producing Klebsiella pneumoniae in Diabetes-Related Foot Disease

Renata Barbosa; Susana Garrido; Luís Costa; Rui Carvalho

doi:10.20344/amp.22152

Medical Treatment of Osteomyelitis due to Carbapenemase-Producing Klebsiella pneumoniae in Diabetes-Related Foot Disease

Authors

Renata Barbosa Division of Endocrinology, Diabetes and Metabolism. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto.
Susana Garrido Division of Endocrinology, Diabetes and Metabolism. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto; Diabetic Foot Clinic “Dr.ª Beatriz Serra”. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto.
Luís Costa Diabetic Foot Clinic “Dr.ª Beatriz Serra”. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto; Division of Orthopedics. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto.
Rui Carvalho Division of Endocrinology, Diabetes and Metabolism. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto; Diabetic Foot Clinic “Dr.ª Beatriz Serra”. Centro Hospitalar e Universitário de Santo António. Unidade Local de Saúde de Santo António. Porto.

DOI:

https://doi.org/10.20344/amp.22152

Keywords:

Carbapenem-Resistant Enterobacteriaceae, Diabetic Foot, Klebsiella Infections, Klebsiella pneumoniae, Osteomyelitis

Abstract

N/A

Downloads

Download data is not yet available.

References

Lazaro Martinez JL, Garcia Alvarez Y, Tardaguila-Garci A, Garcia Morales E. Optimal management of diabetic foot osteomyelitis: challenges and solutions. Diabetes Metab Syndr Obes. 2019;12:947-59.

Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40:e3687.

Davido B, Crémieux AC, Vaugier I, Gatin L, Noussair L, Massias L, et al. Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2023;61:106702.

Boulton AJ, Armstrong DG, Hardman MJ, Malone M, Embil JM, Attinger CE, et al. Diagnosis and management of diabetic foot infections. Virginia: American Diabetes Association; 2020.

Lipsky BA, Uçkay I. Treating diabetic foot osteomyelitis: a practical state-of-the-art update. Medicina. 2021:57:339.

Downloads

Published

2025-01-02

How to Cite

Barbosa R, Garrido S, Costa L, Carvalho R. Medical Treatment of Osteomyelitis due to Carbapenemase-Producing Klebsiella pneumoniae in Diabetes-Related Foot Disease. Acta Med Port [Internet]. 2025 Jan. 2 [cited 2025 Jan. 7];38(1):55-6. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/22152

Download Citation

Issue

Vol. 38 No. 1 (2025): January

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.